Anapneo Therapeutics is Drug Discovery in United States that focus on developer business. Founded in 2014. They cover business area such as developer, medication, sleep, novel compound, its associated co, morbidity, patient, risk, potentially life-threaten long-term effect, hypertension, heart disease, stroke, type ii diabete.
2014
( 12 years old in 2026 )
Developer
-
251 Little Falls Drive
Wilmington, DE 19807
United States
Private
developermedicationsleepnovel compoundits associated comorbiditypatientriskpotentially life-threaten long-term effecthypertensionheart diseasestroketype ii diabete
* We use standard office opening hours in near Anapneo Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Anapneo Therapeutics is Drug Discovery business from United States that founded in 2014 (12 years old in 2026), Anapneo Therapeutics business is focusing on Developer.
Anapneo Therapeutics headquarter office and corporate office address is located in 251 Little Falls Drive Wilmington, DE 19807 United States.
Anapneo Therapeutics was founded in United States.
In 2026, Anapneo Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Anapneo Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
